Neurotune AG

New hope for patients with fatal neuromuscular diseases such as SMA or ALS.

  • Stage Product In Development
  • Industry Biotechnology
  • Location 8048 Schlieren, ZH, Switzerland
  • Currency CHF
  • Founded February 2005
  • Employees 5
  • Website neurotune.com

Company Summary

Neurotune is a clinical stage, R&D focused biotech company. The focus is on the development of novel drugs for neuromuscular diseases (including sarcopenia), neuropatic pain and kidney diagnostic.

Team

  • Armin W. Mäder
    CEO

    Armin Mäder held senior positions in biotech and medtech companies such as Institut Straumann AG. He was the CFO/COO of the biotech start-up company AC Immune SA in Lausanne, Switzerland. Armin Mäder started his professional career in the UBS Investment Bank where he has worked in business development and business management.

    Armin Mäder holds an M.B.A. from IMD and a PhD in Molecular Biology and Biophysics from ETH Zurich.

  • Stefan Hettwer
    Head R&D

    Stefan has more than 10 years of experience in preclinical development of small molecule, protein drug candidates as well as diagnostic assays (ELISA). Prior to working for Neurotune AG that he joined in 2005, he drove the neurotrypsin/agrin research in Prionics as well as the University of Zurich.

    Stefan obtained his Doctorate in Biochemistry from the University of Cologne in 2001.

  • Bruno Oesch
    Chairman

    Bruno Oesch initiated Neurotune as a spin-off from Prionics AG in 2005. Since the start of the company he served as the Chairman of the Board of directors. 2009/10 he also was CEO and currently acts as Chairman with a focus on BD&L.

    Previously, Bruno also co-founded Prionics. He graduated from the ETH Zurich with a Master's degree in Natural Sciences and obtained his PhD from the University of Zurich in 1987.

Advisors

  • Badertscher Rechtsanwälte, Zürich, Switzerland
    Lawyer
    Unconfirmed
    BDO AG (auditor)
    Accountant
    Unconfirmed

Previous Investors

  • Private investors
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free